Related Experiment Video
Updated: Jul 13, 2026

10:24
Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
10.7K
Functional Outcomes Across High-Risk OCT-Based Phenotypes in Intermediate Age-Related Macular Degeneration-PINNACLE
Marie Louise Enzendorfer1, Julia Mai1,2, Sophie Riedl1,2
1Laboratory for Ophthalmic Image Analysis, Medical University of Vienna, Vienna, Austria.
Investigative Ophthalmology & Visual Science
|December 17, 2025
Summary
Structural optical coherence tomography (OCT) biomarkers predict visual function in intermediate age-related macular degeneration (iAMD). Identifying iAMD phenotypes with OCT aids risk assessment and clinical trial patient selection.
Area of Science:
- Ophthalmology
- Medical Imaging
- Retinal Diseases
Background:
- Intermediate age-related macular disease (iAMD) is a significant cause of vision impairment.
- Optical coherence tomography (OCT) provides detailed structural imaging of the retina.
- Understanding the link between OCT biomarkers and visual function in iAMD is crucial for management.
Purpose of the Study:
- To assess the association between OCT biomarkers and visual function in iAMD.
- To determine if OCT-based stratification identifies iAMD phenotypes with poor visual function.
Main Methods:
- Analysis of OCT imaging, microperimetry, and visual acuity tests from the PINNACLE trial cohort.
- Quantification of drusen volume, outer nuclear layer (ONL), and ellipsoid zone (EZ) thickness.
- Linear mixed-effect models to evaluate associations and stratify eyes into phenotypes.
Main Results:
- Subretinal drusenoid deposits (SDDs) and retinal atrophy markers correlated with reduced retinal sensitivity.
- Increased drusen volume and decreased ONL/EZ thickness were linked to lower sensitivity.
- Hyperreflective foci (HRF) and drusen volume changes affected best-corrected visual acuity (BCVA), low-luminance visual acuity (LLVA), and low-luminance deficits (LLDs).
- Distinct iAMD phenotypes showed significant functional differences, particularly those with early atrophy.
Conclusions:
- Integrating OCT biomarkers and functional assessments reveals iAMD phenotypes associated with significant visual deficits.
- Early atrophy markers identified via OCT are important for patient selection and risk stratification in clinical trials and practice.

